Related Experiment Video
Updated: Apr 30, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation
Peter Altevogt1, Niko P Bretz1, Johannes Ridinger2
1Translational Immunology, D015, German Cancer Research Center, DKFZ, 69120 Heidelberg, Germany.
Abstract:
The immune system of cancer patients is often suppressed. Accumulating evidence suggests that exosomes released from tumor cells may play an essential role in this process but the mechanisms are not fully understood. Here we review recent papers showing that exosomes trigger the release of cytokines/chemokines from immune cells. We suggest that this process will either result in the stimulation of anti-tumor immune reactions or in a systemic immunosuppression. The direction appears to be largely dependent on the duration of interactions between immune cells and exosomes leading to the accumulation of inflammatory factors, i.e. on the length of the exposure to these factors. We propose that a long-term interaction of the immune system with elevated levels of tumor exosomes contributes to the development of immunosuppression in cancer patients.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Tumor Immunotherapy
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

